A computational framework for the analysis of peptide microarray antibody binding data with application to HIV...

Area of Science:

• Immunology
• Bioinformatics
• Computational Biology

Background:

• Peptide microarrays are vital for studying antibody responses.
• Existing normalization methods for peptide microarray data often fail to address non-specific binding, leading to systematic biases and reduced accuracy.

Purpose of the Study:

• To present an integrated analytical method for peptide microarray antibody binding data analysis.
• To improve the normalization process by accounting for non-specific binding and reducing signal variability.
• To establish a robust method for subject-specific positivity calls and data visualization.

Main Methods:

• Developed a novel normalization technique utilizing peptide sequence information to reduce systematic biases.
• Employed a sliding mean window for reduced signal variability by leveraging peptides with similar sequences.
• Implemented a principled False Discovery Rate (FDR) method for setting positivity thresholds.
• Utilized baseline control measurements for subject-specific positivity calls.

Main Results:

• The novel normalization method effectively reduced systematic biases in peptide microarray data.
• Signal variability was significantly reduced, enabling better detection of weak antibody binding hotspots.
• The FDR method and use of baseline controls balanced sensitivity and specificity for accurate positivity calls.
• The computational framework was validated using data from two HIV-1 vaccine clinical trials.

Conclusions:

• The integrated analytical method provides a comprehensive solution for peptide microarray antibody binding data analysis.
• The novel normalization and positivity calling methods enhance the reliability and sensitivity of antibody response detection.
• This framework is crucial for accurate assessment of immune responses in vaccine development and clinical trials.